Korean J Urol Oncol.
2017 Dec;15(3):131-136. 10.22465/kjuo.2017.15.3.131.
The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea
- Affiliations
-
- 1Department of Urology, Chungbuk National University Hospital, Cheongju, Korea. sjyun@chungbuk.ac.kr
- 2Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.
- 3Department of Public Health and Preventive Medicine, Chungbuk National University Hospital, Cheongju, Korea.
- 4Department of Preventive Medicine/Graduate School of Health Science Business Convergence, Chungbuk National University, Cheongju, Korea.
- KMID: 2402594
- DOI: http://doi.org/10.22465/kjuo.2017.15.3.131
Abstract
- PURPOSE
The aim of this study is to investigate the criteria of biochemical recurrence (BCR) and follow-up periods and methods with and without blood and imaging test of urologic oncology before established guidelines of prostate cancer in Korea.
MATERIALS AND METHODS
In December 2015, we sent the questionnaire to urologic oncologist in academic hospital and received the answer from 108 urologic oncologist (50%). Also, we analyzed the data of 1,141 patients underwent radical prostatectomy in 2005 from Korean Medical Insurance.
RESULTS
In follow-up, 72 physicians (66.7%) performed blood test every 3 months, 51 physicians (47.2%) performed imaging study in case of BCR. Bone scan was the most common imaging study in the follow-up (74 physicians, 68.5%). But, bone scan was only performed in case of BCR (43 physicians, 39.8%). The criteria of BCR was PSA 0.2 ng/mL (75 physician, 69.4%), 76 physicians (70.4%) was performed different follow-up according to risk of patients. In Korean Medical Insurance data analysis, PSA were performed average 2 times every year and magnetic resonance imaging, computed tomography, Bone scan were performed average 0.1, 0.2, 0.1 times every year, respectively.
CONCLUSIONS
The criteria of BCR and the follow-up of prostate cancer patients in Korea were similar Korean prostate cancer guidelines. Blood and imaging test might be increased compared to 10 years ago, it is necessary to compare the Korean Medical Insurance data between 10 years ago and present.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Recurrence of Chronic Pelvic Pain Syndrome and the Role of Uro-Vaxom(R)
- The Comprehension of Hospice-Palliative Care and Self-determination Life Sustaining Decision-Making Act as Uro-Oncologist
- Efficacy of I-123/I-131 Metaiodobenzylguanidine Scan as A Single Initial Diagnostic Modality in Pheochromocytoma: Comparison with Biochemical Test and Anatomic Imaging
- The Clinical Efficacy of Uro-Vaxom(R)in the Treatment of Recurrent Urinary Tract Infections
- A Study on the Cell Surface Antigens of Bladder Carcinoma by Means of Monoclonal Antibodies
